Brief: Lucid Diagnostics Reports Q2 GAAP Loss Per Share $0.41

Lucid Diagnostics

15/08/2022 21:48

Aug 15 (Reuters) - Lucid Diagnostics Inc  LUCD.O :
    * Q2 PRELIMINARY ADJUSTED NON-GAAP LOSS PER SHARE $0.28
    * Q2 GAAP LOSS PER SHARE $0.41
    * LUCID HAD CASH AND CASH EQUIVALENTS OF $32.7 MILLION AS OF
JUNE
30, 2022
    * PRELIMINARY NON-GAAP ADJUSTED LOSS FOR THREE MONTHS ENDED
JUNE
30, 2022, WAS $0.28 PER COMMON SHARE

Source text for Eikon:  ID:nBw8XBpBYa 
Further company coverage:  LUCD.O 

 ((Reuters.Briefs@thomsonreuters.com;))